Solid Biosciences Inc. - Common Stock (NQ:SLDB)

7.190 -0.040 (-0.55%)

Delayed Quote Updated: 1:43 PM EDT, Oct 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Solid Biosciences Inc. - Common Stock

Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors

April 01, 2025

Appointments Include Industry Veterans Kim Cobleigh Drapkin, CPA, and Bo Cumbo as Independent Directors

From Climb Bio, Inc.

Via GlobeNewswire

Solid Biosciences Inc. (NASDAQ: SLDB) Near the Top of Equities by Percentage Gain on 11/15

November 15, 2023

Via Investor Brand Network

Are Gene Therapy Stocks The Market's Next Big Winners?

September 25, 2023

Biotechs Sarepta and BioMarin are among companies advancing cutting-edge gene therapies, although those treatments can come with a $2 million or more price.

Via MarketBeat

Topics Artificial Intelligence

SOLID BIOSCIENCES INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Solid Biosciences Inc. - SLDB

November 12, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

SOLID BIOSCIENCES INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Solid Biosciences Inc. - SLDB

September 30, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

SLDB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Solid Biosciences Inc. Is Fair to Shareholders

September 30, 2022

From Halper Sadeh LLC

Via Business Wire

Solid Biosciences and Forge Biologics Announce Viral Vector Contract Development and cGMP Manufacturing Partnership

October 04, 2021

From Forge Biologics and Solid Biosciences Inc.

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.